Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Promising Opportunities for Cardiovascular Monitoring Equipment in Europe

By HospiMedica International staff writers
Posted on 03 Oct 2008
Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe. More...
The need for sophisticated, yet user-friendly equipment at affordable rates will offer market participants considerable growth opportunities in this sector.

These are the latest findings of Frost and Sullivan (Palo Alto, CA, USA), an international consulting firm. Cardiovascular diseases are one of the leading causes of premature death; furthermore, statistics have revealed that one in five teenagers suffers from the early signs of heart disease. Additionally, lifestyle changes and an aging population underpin the increasing incidence of cardiovascular-related illnesses. These trends are contributing to an increased need for diagnostic cardiovascular monitoring equipment, which are finding wider application in hospitals and cardiac rehabilitation centers to enable effective diagnosis and therapy.

However, while ECG is a well-established procedure, there have not been significant technologic breakthroughs in recent years and the market continues to persist with old technologies. This situation has been exacerbated by the lack of funds for the research and development of innovative technologies. Moreover, a persistent focus on treatment, rather than monitoring modalities, is threatening to impede market momentum. Market expansion is expected to be sustained by technological enhancements that promote greater user friendliness and improve networking and communication capabilities, while supporting cost efficiencies. In the future, growth opportunities will exist for companies that will be able to form strategic alliances to meet evolving end-user demands, despite intense competition among themselves.

"Larger participants have always had the upper hand because of their reputation and the superior brand awareness that they have been able to create. This is threatening the survival of smaller competitors,” said Frost & Sullivan research analyst Gideon V. Praveen Kumar.

Frost & Sullivan has found that the cardiovascular monitoring equipment market in Europe earned revenues of US$350 million in 2007 and estimates this to reach $491 million in 2014.

Related Links:
Frost and Sullivan



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.